dronabinol
Generic: dronabinol
Labeler: ascend laboratories, llcDrug Facts
Product Profile
Brand Name
dronabinol
Generic Name
dronabinol
Labeler
ascend laboratories, llc
Dosage Form
CAPSULE
Routes
Active Ingredients
dronabinol 2.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
67877-753
Product ID
67877-753_ef3763f7-d386-4bbb-bda6-264e3a99593b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA018651
DEA Schedule
ciii
Listing Expiration
2026-12-31
Marketing Start
2021-03-03
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
67877753
Hyphenated Format
67877-753
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dronabinol (source: ndc)
Generic Name
dronabinol (source: ndc)
Application Number
NDA018651 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2.5 mg/1
Packaging
- 60 CAPSULE in 1 BOTTLE (67877-753-60)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ef3763f7-d386-4bbb-bda6-264e3a99593b", "openfda": {"nui": ["N0000175782", "M0003267"], "upc": ["0367877755601", "0367877753607", "0367877754604"], "unii": ["7J8897W37S"], "rxcui": ["197634", "197635", "197636"], "spl_set_id": ["adb1801c-0fb5-4e16-b969-1db91230e0b9"], "pharm_class_cs": ["Cannabinoids [CS]"], "pharm_class_epc": ["Cannabinoid [EPC]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (67877-753-60)", "package_ndc": "67877-753-60", "marketing_start_date": "20210303"}], "brand_name": "Dronabinol", "product_id": "67877-753_ef3763f7-d386-4bbb-bda6-264e3a99593b", "dosage_form": "CAPSULE", "pharm_class": ["Cannabinoid [EPC]", "Cannabinoids [CS]"], "product_ndc": "67877-753", "dea_schedule": "CIII", "generic_name": "Dronabinol", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dronabinol", "active_ingredients": [{"name": "DRONABINOL", "strength": "2.5 mg/1"}], "application_number": "NDA018651", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20210303", "listing_expiration_date": "20261231"}